The protective effects of silymarin in 5-fluorouracil-ınduced hepatotoxicity and nephrotoxicity in rats

Document Type : Research Paper

Authors

1 Assistant Professor, Department of Basic Sciences, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran

2 Assistant Professor, Department of Pathobiology, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran

3 Professor, Department of Clinical Sciences, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran

4 DVM Graduated, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran

Abstract

    Silymarin as an antioxidant compound has hepatic and renal protection effects. Numerous studies have reported liver and kidney damage caused by 5-fluorouracil (5-FU). Hence, the present study aimed to evaluate the protective effects of silymarin against 5-FU-induced hepatotoxicity and nephrotoxicity. Rats were divided into three groups: control (distilled water + dimethyl sulfoxide1ml/day intraperitoneal for two weeks), 5-FU (distilled water + dimethyl sulfoxide1ml/day intraperitoneal from the first day to the end of the eighth day along with 20mg/kg of 5-FU from the ninth to the end of the study), and 5-FU + silymarin (50mg/kg silymarin /day intraperitoneal for 2 weeks along with 20mg/kg of 5-FU from the ninth day to the fourteenth day). At the end of the experiment, the rats were killed and blood samples were taken for measuring serum alanine aminotransferase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH), blood urea nitrogen (BUN), creatinine, and antioxidant activities. Also, liver and kidney tissues were sampled. Results revealed that the activities of ALP, ALT, AST, and LDH in the 5-FU group were higher than in the control group, while their activities were similar in both silymarin and control groups. The silymarin group had a significant decrease (20.64%) in urea compared to the 5-FU group. Also, the silymarin group had significant increases (37.47%) in total antioxidant capacity compared to the 5-FU group. Histopathological analyses of the liver revealed the hepatic focal necrosis and renal epithelial necrosis in the 5-FU group compared to the control group. However, there were not notable pathologic changes to liver and kidney tissues of the silymarin group. It was concluded that silymarin had the protective effects on 5-FU-induced hepatotoxicity and nephrotoxicity.

Keywords

References

Abdulrazzaq, A. M., Badr, M., Gammoh, O., Abu Khalil, A. A., Ghanim, B. Y., Alhussainy, T. M., & Qinna, N. A. (2019). Hepatoprotective actions of ascorbic acid, alpha lipoic acid and silymarin or their combination against acetaminophen-induced hepatotoxicity in rats. Medicina, 55(5), 181.
Anthony, K. P., & Saleh, M. A. (2013). Free radical scavenging and antioxidant activities of silymarin components. Antioxidants, 2(4), 398-407.
Alvarez-Cabellos, R., Garcia-Carbonero, R., Garcia-Lacalle, C., Gomez, P., Tercero, A., Sanchez, D., & Paz-Ares, L. (2007). Fluorouracil-based chemotherapy in patients with gastrointestinal malignancies: influence of nutritional folate status on toxicity. Journal of chemotherapy (Florence, Italy), 19(6), 744–749.
Baradaran, A., Samadi, F., Ramezanpour, S. S., & Yousefdoust, S. (2019). Hepatoprotective effects of silymarin on CCl4-induced hepatic damage in broiler chickens model. Toxicology reports, 6, 788-794.
Behling, E. B., Sendão, M. C., Francescato, H. D., Antunes, L. M., Costa, R. S., & Bianchi, M. D. L. P. (2006). Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacological reports, 526-532.
Boilève, A., Thomas, L., Lillo-Le Louët, A., Gaboriau, L., Chouchana, L., Ducreux, M., ... & Jozwiak, M. (2020). 5-Fluorouracil-induced hyperammonaemic encephalopathy: A French national survey. European Journal of Cancer, 129, 32-40.
Darvishi-Khezri, H., Salehifar, E., Kosaryan, M., Karami, H., Alipour, A., Shaki, F., & Aliasgharian, A. (2017). The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial. Complementary Therapies in Medicine, 35, 25-32.
Davey, M. W., Stals, E., Panis, B., Keulemans, J., & Swennen, R. L. (2005). High-throughput determination of malondialdehyde in plant tissues. Analytical biochemistry, 347(2), 201-207.
Durak, İ., Cetin, R., Devrim, E., & Ergüder, İ. B. (2005). Effects of black grape extract on activities of DNA turn-over enzymes in cancerous and non cancerous human colon tissues. Life sciences, 76(25), 2995-3000.
El-Abd, S. F. (2015). Effect of Silymarin on Ribavirin-induced Molecular and Histopathological Changes. THE EGYPTIAN JOURNAL OF EXPERIMENTAL BIOLOGY (Zoology), 1.
Elmowafy, M., Viitala, T., Ibrahim, H. M., Abu-Elyazid, S. K., Samy, A., Kassem, A., & Yliperttula, M. (2013). Silymarin loaded liposomes for hepatic targeting: in vitro evaluation and HepG2 drug uptake. European journal of pharmaceutical sciences, 50(2), 161-171.
Farjad, E., & Momeni, H. R. (2018). Silymarin Ameliorates Oxidative Stress and Enhances Antioxidant Defense System Capacity in Cadmium-Treated Mice. Cell journal, 20(3), 422–426.
Freitag, A. F., Cardia, G. F. E., da Rocha, B. A., Aguiar, R. P., Silva-Comar, F. M. D. S., Spironello, R. A., ... & Cuman, R. K. N. (2015). Hepatoprotective effect of silymarin (Silybum marianum) on hepatotoxicity induced by acetaminophen in spontaneously hypertensive rats. Evidence-Based Complementary and Alternative Medicine, 2015.
Gargari, B. P., Mobasseri, M., Valizadeh, H., & Asghari-Jafarabadi, M. (2015). Effects of Silybum marianum (L.) Gaertn.(silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine, 22(2), 290-296.
Gazak, R., Walterova, D., & Kren, V. (2007). Silybin and silymarin-new and emerging applications in medicine. Current medicinal chemistry, 14(3), 315-338.
Gebhardt, R. (2002). Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta medica, 68(04), 289-296.
Gelen, V., Şengül, E., Gedikli, S., Atila, G., Uslu, H., & Makav, M. (2017). The protective effect of rutin and quercetin on 5-FU-induced hepatotoxicity in rats. Asian Pacific Journal of Tropical Biomedicine, 7(7), 647-653.
Gelen, V., Şengül, E., Yıldırım, S., & Atila, G. (2018). The protective effects of naringin against 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats. Iranian journal of basic medical sciences, 21(4), 404.
Gelen, V., Şengül, E., Yıldırım, S., Senturk, E., Tekin, S., & Kükürt, A. (2021). The protective effects of hesperidin and curcumin on 5-fluorouracil-induced nephrotoxicity in mice. Environmental science and pollution research international, 28(34), 47046–47055. https://doi.org/10.1007/s11356-021-13969-5
Guzel, S., Sahinogullari, Z. U., Canacankatan, N., Antmen, S. E., Kibar, D., & Coskun Yilmaz, B. (2020). Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. Drug and chemical toxicology, 43(6), 630–636. https://doi.org/10.1080/01480545.2019.1584208
Inoue, K., Nagasawa, Y., Yamamoto, R., Omori, H., Kimura, T., Tomida, K., & Rakugi, H. (2009). Severe adverse effects of 5-fluorouracil in S-1 were lessened by haemodialysis due to elimination of the drug. NDT plus, 2(2), 152-154.
Jouhari, S., Mohammadzadeh, A., Soltanghoraee, H., Mohammadi, Z., Khazali, S., Mirzadegan, E & Naderi, M. M. (2018). Effects of silymarin, cabergoline and letrozole on rat model of endometriosis. Taiwanese Journal of Obstetrics and Gynecology, 57(6), 830-835.
Karimi, G., Vahabzadeh, M., Lari, P., Rashedinia, M., & Moshiri, M. (2011). “Silymarin”, a promising pharmacological agent for treatment of diseases. Iranian journal of basic medical sciences, 14(4), 308.
Karimi, G., Ramezani, M., & Tahoonian, Z. (2005). Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evidence-Based Complementary and Alternative Medicine, 2(3), 383-386.
Kummer, V., Maskova, J., Canderle, J., Zraly, Z., Neca, J., & Machala, M. (2001). Estrogenic effects of silymarin in ovariectomized rats. VETERINARNI MEDICINA-PRAHA-, 46(1), 17-23.
Liu, X. Y., Zhang, F. R., Shang, J. Y., Liu, Y. Y., Lv, X. F., Yuan, J. N., ... & Liang, S. J. (2018). Renal inhibition of miR-181a ameliorates 5-fluorouracil-induced mesangial cell apoptosis and nephrotoxicity. Cell death & disease, 9(6), 1-14.
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003). 5-fluorouracil: mechanisms of action and clinical strategies. Nature reviews cancer, 3(5), 330-338.
Loguercio, C., & Festi, D. (2011). Silybin and the liver: from basic research to clinical practice. World journal of gastroenterology: WJG, 17(18), 2288.
Matouk, A. I., Taye, A., Heeba, G. H., & El-Moselhy, M. A. (2013). Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environmental toxicology and pharmacology, 36(2), 443-450.
Mohamadifard, M., Nazem, H., & Mottaghipisheh, J. (2016). The effects of copper oxide nanoparticles and hydroalcoholic extracts of berberis vulgaris, descurainia sophia and silybum marianum on catalase, glutathione peroxidase, and malondialdehyde concentration in male diabetic rats. Journal of Babol University of Medical Sciences, 18(3), 54-61.
Osuchowski, M., Johnson, V., He, Q., & Sharma, R. (2004). Alterations in regional brain neurotransmitters by silymarin, a natural antioxidant flavonoid mixture, in BALB/c mice. Pharmaceutical biology, 42(4-5), 384-389.
Pradhan, S. C., & Girish, C. (2006). Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian journal of medical research, 124(5), 491.
Pujari, R. R., & Bandawane, D. D. (2021). Hepatoprotective activity of gentisic acid on 5-fluorouracil-induced hepatotoxicity in wistar rats. Turkish Journal of Pharmaceutical Sciences, 18(3), 332.
Rani, V. S., Kumar, A. K., Kumar, C. P., & Reddy, A. R. N. (2013). Pulmonary toxicity of copper oxide (CuO) nanoparticles in rats. Journal of medical sciences, 13(7), 571.
Rashid, S., Ali, N., Nafees, S., Hasan, S. K., & Sultana, S. (2014). Mitigation of 5-Fluorouracil induced renal toxicity by chrysin via targeting oxidative stress and apoptosis in wistar rats. Food and Chemical Toxicology, 66, 185-193.
Ray, S., Roy, K. U. N. A. L., & Sengupta, C. H. A. N. D. A. N. A. (2007). In vitro evaluation of protective effects of ascorbic acid and water extract of Spirulina plantesis (blue green algae) on 5-fluorouracil-induced lipid peroxidation. Acta Pol Pharm, 64(4), 335-344.
Saller, R., Brignoli, R., Melzer, J., & Meier, R. (2008). An updated systematic review with meta-analysis for the clinical evidence of silymarin. Complementary Medicine Research, 15(1), 9-20.
Sara, J. D., Kaur, J., Khodadadi, R., Rehman, M., Lobo, R., Chakrabarti, S., ... & Grothey, A. (2018). 5-fluorouracil and cardiotoxicity: a review. Therapeutic advances in medical oncology, 10, 1758835918780140.
Shahbazi, F., Dashti-Khavidaki, S., Khalili, H., & Lessan-Pezeshki, M. (2012). Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature. Journal of Pharmacy & Pharmaceutical Sciences, 15(1), 112-123.
Swamy, A. V., Patel, U. M., Koti, B. C., Gadad, P. C., Patel, N. L., & Thippeswamy, A. H. M. (2013). Cardioprotective effect of Saraca indica against cyclophosphamide induced cardiotoxicity in rats: a biochemical, electrocardiographic and histopathological study. Indian journal of pharmacology, 45(1), 44.
Taleb, A., Ahmad, K. A., Ihsan, A. U., Qu, J., Lin, N. A., Hezam, K., ... & Qilong, D. (2018). Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine & Pharmacotherapy, 102, 689-698.
Vangaveti, S., Das, P., & Kumar, V. L. (2021). Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation. Journal of biochemical and molecular toxicology, 35(1), e22614.
Watson, E. M. (2006). An introductory guide to drug reference sources. Medical Reference Services Quarterly, 25(1), 37-48.
Wolf, P. S., Park, J. O., Bao, F., Allen, P. J., DeMatteo, R. P., Fong, Y., ... & D'Angelica, M. I. (2013). Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience. Journal of the American College of Surgeons, 216(1), 41-49.
Yaegashi, A., Yoshida, K., Suzuki, N., Shimada, I., Tani, Y., Saijo, Y., & Toyama, A. (2020, January). A case of severe hepatotoxicity induced by cisplatin and 5-fluorouracil. In International Cancer Conference Journal (Vol. 9, No. 1, pp. 24-27). Springer Singapore.
Yousef, H. N., & Aboelwafa, H. R. (2017). The potential protective role of taurine against 5-fluorouracil-induced nephrotoxicity in adult male rats. Experimental and Toxicologic Pathology, 69(5), 265-274.
Iranian Veterinary Journal
Volume 18, Issue 3 - Serial Number 76
November 2022
Pages 103-113

Files

Share

How to cite

Statistics